» Articles » PMID: 33554647

Exosomal MicroRNAs in Cancer-related Sarcopenia: Tumor-derived Exosomal MicroRNAs in Muscle Atrophy

Overview
Specialty Biology
Date 2021 Feb 8
PMID 33554647
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer-associated sarcopenia is a complex metabolic syndrome marked by muscle mass wasting. Muscle wasting is a serious complication that is a primary contributor to cancer-related mortality. The underlying molecular mechanisms of cancer-associated sarcopenia have not been completely described to date. In general, evidence shows that the main pathophysiological alterations in sarcopenia are associated with the degradation of cellular components, an exceptional inflammatory secretome and mitochondrial dysfunction. Importantly, we highlight the prospect that several miRNAs carried by tumor-derived exosomes that have shown the ability to promote inflammatory secretion, activate catabolism, and even participate in the regulation of cellular degradation pathways can be delivered to and exert effects on muscle cells. In this review, we aim to describe the current knowledge about the functions of exosomal miRNAs in the induction of cancer-associated muscle wasting and propose potential treatment strategies.

Citing Articles

Exercise-induced extracellular vesicles in reprogramming energy metabolism in cancer.

Puurand M, Llorente A, Line A, Kaambre T Front Oncol. 2025; 14():1480074.

PMID: 39834935 PMC: 11743358. DOI: 10.3389/fonc.2024.1480074.


Myogenic microRNAs as Therapeutic Targets for Skeletal Muscle Mass Wasting in Breast Cancer Models.

Artigas-Arias M, Curi R, Marzuca-Nassr G Int J Mol Sci. 2024; 25(12).

PMID: 38928418 PMC: 11204047. DOI: 10.3390/ijms25126714.


The Role of Exercise in Cancer-Related Sarcopenia and Sarcopenic Obesity.

Papadopetraki A, Giannopoulos A, Maridaki M, Zagouri F, Droufakou S, Koutsilieris M Cancers (Basel). 2023; 15(24).

PMID: 38136400 PMC: 10741686. DOI: 10.3390/cancers15245856.


Extracellular Vesicles for Muscle Atrophy Treatment.

Su X, Shen Y, Kim I, Weintraub N, Hamrick M, Tang Y Adv Exp Med Biol. 2023; 1418:119-126.

PMID: 37603276 DOI: 10.1007/978-981-99-1443-2_8.


Immunoregulation in cancer-associated cachexia.

Wu Q, Liu Z, Li B, Liu Y, Wang P J Adv Res. 2023; 58:45-62.

PMID: 37150253 PMC: 10982873. DOI: 10.1016/j.jare.2023.04.018.


References
1.
Zhang L, Pan J, Dong Y, Tweardy D, Dong Y, Garibotto G . Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass. Cell Metab. 2013; 18(3):368-79. PMC: 3794464. DOI: 10.1016/j.cmet.2013.07.012. View

2.
Grimolizzi F, Monaco F, Leoni F, Bracci M, Staffolani S, Bersaglieri C . Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression. Sci Rep. 2017; 7(1):15277. PMC: 5681649. DOI: 10.1038/s41598-017-15475-6. View

3.
Kir S, White J, Kleiner S, Kazak L, Cohen P, Baracos V . Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature. 2014; 513(7516):100-4. PMC: 4224962. DOI: 10.1038/nature13528. View

4.
Argiles J, Lopez-Soriano F, Busquets S . Mediators of cachexia in cancer patients. Nutrition. 2019; 66:11-15. DOI: 10.1016/j.nut.2019.03.012. View

5.
Tomasetti M, Monaco F, Manzella N, Rohlena J, Rohlenova K, Staffolani S . MicroRNA-126 induces autophagy by altering cell metabolism in malignant mesothelioma. Oncotarget. 2016; 7(24):36338-36352. PMC: 5095004. DOI: 10.18632/oncotarget.8916. View